NCT03435614
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +1 more
- Locations
-
- McGill University Health Centre Montreal, Quebec, Canada
Clinical trial condition
Substance Withdrawal Syndrome
Explore clinical trials studying Substance Withdrawal Syndrome. Study availability and eligibility vary by location and protocol.
60 public trials
5 recruiting studies
Substance Withdrawal Syndrome trial results
NCT03557294
- Conditions
- Behavior, Chemically-Induced Disorders, Health Behavior, +7 more
- Locations
-
- Arizona State University Phoenix, Arizona, United States
- Los Angeles Clinical Trials Burbank, California, United States
NCT03996096
- Conditions
- Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more
- Locations
-
- University hospital Caen, France
Completed
Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients
NCT06029634
- Conditions
- Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +20 more
- Locations
-
- Changhai hospital Shanghai, China
NCT04320381
- Conditions
- Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +10 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
- Boston Children's Hospital Boston, Massachusetts, United States
NCT05336656
- Conditions
- ARDS, COVID-19, Chemically-Induced Disorders, +20 more
- Locations
-
- Wilkes University Wilkes-Barre, Pennsylvania, United States
Completed
Opioid Tapering After Spine Surgery
NCT04140955
- Conditions
- Behavior, Chemically-Induced Disorders, Health Behavior, +14 more
- Locations
-
- Aarhus University Hospital Aarhus, Central Jutland, Denmark
NCT04422808
- Conditions
- Chemically-Induced Disorders, Critical Illness, Disease Attributes, +7 more
- Locations
-
- Wilkes University Wilkes-Barre, Pennsylvania, United States
NCT02952846
- Conditions
- Chemically-Induced Disorders, Child, Critical Care, +4 more
- Locations
-
- Oslo University Hospital, Rikshospitalet Oslo, Norway
Completed
Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
NCT04731935
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Recovery Unplugged Austin, Texas, United States